Milestone Paves the Way for Commercialization, Unlocks New Research PotentialNEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation…
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…
April 17, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical…
ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced…
Contrave is taken to help people lose weight. It is a combination of two medicines that work in the brain…
Best Berberine Supplement for Weight loss and Blood sugar. It is used for centuries in traditional medicine, berberine is now…
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~…
Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn.,…
The Toolkit Fosters Safe and Inclusive Learning Environments for Students with EpilepsyBOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The…
SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa…